VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
EW
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
EWEdwards Lifesciences Corporation
$102.14$58.8B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksEWQuarterly Financials

Edwards Lifesciences Corporation (EW) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Edwards Lifesciences Corporation (EW) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

EW Income Statement

Quarterly statement

EW Income Statement

Edwards Lifesciences Corporation (EW) annual income statement — 27-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue1.72B1.74B1.65B1.57B1.55B1.53B1.41B1.39B1.35B1.39B1.33B1.27B1.24B1.3B1.46B1.35B1.32B1.37B1.34B1.33B
Revenue Growth %10.46%13.63%16.7%13.26%14.67%10.56%6.23%9.43%8.93%6.98%-8.89%-6.07%-5.73%-5.71%8.83%1.4%0.67%-0.15%10.24%11.58%
Cost of Goods Sold369.2M390.6M359.3M340.6M345.2M342.6M301.6M292.2M262.9M297.8M289.3M251M272.2M270.8M359.3M295.6M280.9M285.7M306.6M311.1M
COGS % of Revenue21.52%22.44%21.79%21.7%22.23%22.36%21.35%21.09%19.41%21.49%21.75%19.82%21.89%20.9%24.62%21.92%21.3%20.79%22.86%23.4%
Gross Profit1.35B1.35B1.29B1.23B1.21B1.19B1.11B1.09B1.09B1.09B1.04B1.02B971.2M1.02B1.1B1.05B1.04B1.09B1.03B1.02B
Gross Margin %78.48%77.56%78.21%78.3%77.88%77.64%78.65%78.91%80.59%78.51%78.25%80.18%78.11%79.1%75.38%78.08%78.7%79.21%77.14%76.6%
Gross Profit Growth %11.3%13.52%16.04%12.38%10.82%9.33%6.77%7.7%12.39%6.19%-5.43%-3.54%-6.44%-5.84%6.35%3.35%2.85%3.64%11.4%13.59%
Operating Expenses1.05B830.9M774.6M858.7M784.5M758.7M716.3M781M740.9M723.4M685.1M658.7M624.7M654.1M697.5M643.2M610.9M659.8M598.9M656.8M
OpEx % of Revenue61.04%47.73%46.99%54.71%50.51%49.52%50.7%56.36%54.7%52.2%51.52%52.01%50.24%50.49%47.79%47.7%46.32%48.02%44.65%49.39%
Selling, General & Admin560.9M561.2M522.2M602.9M514.6M502M465.7M491.9M421.4M450.8M428.4M416.6M381.9M410.4M436.3M411M377.3M409M370.3M424M
SG&A % of Revenue32.7%32.23%31.68%38.41%33.13%32.76%32.97%35.5%31.11%32.53%32.21%32.9%30.71%31.68%29.89%30.48%28.61%29.77%27.61%31.89%
Research & Development281.4M278.9M263.3M267.7M280.7M276.2M254.6M271.1M253.4M272.6M256.7M242.1M242.8M243.7M261.2M232.2M233.6M250.8M228.6M232.8M
R&D % of Revenue16.4%16.02%15.97%17.06%18.07%18.03%18.02%19.56%18.71%19.67%19.3%19.12%19.53%18.81%17.9%17.22%17.71%18.25%17.04%17.51%
Other Operating Expenses1000K-1000K-1000K-1000K-1000K-1000K-1000K1000K1000K00000000000
Operating Income299.1M519.5M514.7M370.3M425.1M430.9M394.8M312.6M350.6M364.7M355.5M356.7M346.5M370.6M402.8M409.5M427.2M428.4M435.7M361.8M
Operating Margin %17.44%29.84%31.22%23.59%27.37%28.12%27.95%22.56%25.89%26.31%26.73%28.17%27.87%28.61%27.6%30.37%32.39%31.18%32.49%27.21%
Operating Income Growth %-29.64%20.56%30.37%18.46%21.25%18.15%11.05%-12.36%1.18%-1.59%-11.74%-12.89%-18.89%-13.49%-7.55%13.18%4.91%-4.93%11.49%-0.14%
EBITDA344M562.2M555.6M413M464.3M469M431.4M355.2M385.1M404.3M394M393.4M383.4M406.7M444.8M451.5M469.3M469.3M477.5M401.9M
EBITDA Margin %20.05%32.29%33.7%26.31%29.89%30.61%30.54%25.63%28.43%29.17%29.63%31.06%30.83%31.39%30.47%33.49%35.58%34.16%35.6%30.22%
EBITDA Growth %-25.91%19.87%28.79%16.27%20.57%16%9.49%-9.71%0.44%-0.59%-11.42%-12.87%-18.3%-13.34%-6.85%12.34%4.78%-4.88%10.92%-0.12%
D&A (Non-Cash Add-back)44.9M42.7M40.9M42.7M39.2M38.1M36.6M42.6M34.5M39.6M38.5M36.7M36.9M36.1M42M42M42.1M40.9M41.8M40.1M
EBIT363.2M519.5M459M90.4M348.4M362.1M433.9M441.1M394.3M386.6M371.2M367.2M387.6M275.1M398.6M459.3M407.3M465.8M437.1M377.5M
Net Interest Income36.5M30M33.5M35.9M38.6M37.4M19.5M44.2M23.5M16.5M19M16.8M16.3M12.9M6.9M6.3M5.1M-1.1M-1M-1.2M
Interest Income36.5M30M33.5M35.9M38.6M37.4M19.5M44.2M23.5M16.5M19M16.8M16.3M12.9M6.9M6.3M5.1M000
Interest Expense000000000000000001.1M1M1.2M
Other Income/Expense64.1M300K-55.7M-279.9M-76.7M-30.7M39.1M77.5M52.2M21.9M15.7M10.5M41.1M-95.5M-4.2M49.8M-19.9M36.3M400K14.5M
Pretax Income363.2M519.8M459M90.4M348.4M400.2M433.9M390.1M402.8M386.6M371.2M367.2M387.6M275.1M398.6M459.3M407.3M464.7M436.1M376.3M
Pretax Margin %21.17%29.86%27.84%5.76%22.43%26.12%30.71%28.15%29.74%27.9%27.91%29%31.17%21.23%27.31%34.07%30.88%33.82%32.52%28.3%
Income Tax61.8M278.4M78.3M26.2M56.1M64.3M70.3M45.1M40.7M20.2M46.3M34.1M52.7M20.9M58.1M60.9M63.8M58.3M62.5M41M
Effective Tax Rate %17.02%53.56%17.06%28.98%16.1%16.07%16.2%11.56%10.1%5.23%12.47%9.29%13.6%7.6%14.58%13.26%15.66%12.55%14.33%10.9%
Net Income307.5M241.9M380.7M91.2M291.1M329.8M358M385.6M3.07B363.7M351.9M369.9M384.9M307.1M340.5M398.4M343.5M406.4M373.6M335.3M
Net Margin %17.92%13.89%23.09%5.81%18.74%21.52%25.34%27.83%226.73%26.24%26.46%29.21%30.96%23.71%23.33%29.55%26.04%29.58%27.86%25.22%
Net Income Growth %5.63%-26.65%6.34%-76.35%-90.52%-9.32%1.73%4.24%697.82%18.43%3.35%-7.15%12.05%-24.43%-8.86%18.82%1%-16.98%10.47%8.34%
Net Income (Continuing)301.4M241.4M380.7M64.2M292.3M335.9M363.6M345M362.1M366.4M324.9M333.1M334.9M254.2M340.5M398.4M343.5M406.4M373.6M335.3M
Discontinued Operations0001000K-1000K-1000K-1000K1000K1000K-1000K1000K1000K1000K1000K000000
Minority Interest100.4M106.9M00061.2M62.9M64.5M65.8M67.2M68.5M69.4M69.6M70.8M84M00000
EPS (Diluted)0.530.420.660.160.500.560.610.655.130.610.580.610.630.500.560.650.550.650.590.53
EPS Growth %6%-25%8.2%-75.38%-90.25%-8.2%5.17%6.56%714.29%22%3.57%-6.15%14.55%-23.08%-5.08%22.64%1.85%-16.67%9.26%8.16%
EPS (Basic)0.530.420.660.160.500.570.610.655.140.610.580.610.630.510.560.650.550.650.600.54
Diluted Shares Outstanding577.6M577.6M580.7M581.8M585.7M587.9M587.8M590.5M598.1M604.3M604.1M606.9M609.5M610.3M610.9M616.2M624.5M626.7M629.4M632M
Basic Shares Outstanding576.3M576.4M579.2M580.4M584.7M587M586.9M589.8M597.2M602.1M601.6M605.2M607M606.9M607.5M612.9M619.8M620.9M622.1M624.1M
Dividend Payout Ratio--------------------